Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 69.65

-2.6%

Nov 3 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2539)	3/29/2010 10:42:31 AM
From: Jibacoa	Read Replies (1) of 3722

SKBI is trying to move up in spite of significant lower earnings on the 3rdQ.<g> The stock is up 6.59% on low volume, about half its ADV bigcharts.marketwatch.com But the PE remains around 7 and the EE although have been revised down, they are for $0.03 more than the $1.55 in 2008 and another $0.10 improvement is expected for 20111.<g> SKBI has continued to report better revenues and has +CF and around $2 of Csh/shr. The insiders reportedly hold around 30% The stock has resistance at the $12 level before it can test the Nov17 H at $13.50 The ACTAY is $12.33 but I think the stock could make it to the $15 level and R/R is favorable. bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next